BACKGROUND: The value of chronic kidney disease (CKD) screening in the general population remains unclear but may be beneficial in populations with high disease prevalence. We examined risk factors for albuminuria among participants in a state-wide CKD screening program in Hawaii. METHODS: The National Kidney Foundation of Hawaii Kidney Early Detection Screening (NKFH-KEDS) program held 19 CKD screening events from 2006 to 2012. Participants rotated through 5 stations during which sociodemographic, blood glucose, urine albumin-to-creatinine ratio (ACR), and spot urine albumin data were collected. Multivariate logistic regression analyses (adjusted for age, sex, race/ethnicity, body mass index [BMI]) were used to identify clinical predictors of abnormal ACR (≥30 μg/mg) and abnormal spot urine albumin (>20 mg/L) levels. RESULTS: Among 1,190 NKFH-KEDS participants who met eligibility criteria, 13 and 49% had abnormal ACR and urine albumin levels, respectively. In multivariate logistic regression analyses, participants of older age (>65 years), Asian and Pacific Islander race/ethnicity, BMI ≥30 kg/m2, and with hypertension had higher risk of abnormal ACR. Being of older age; Asian, Pacific Islander, and Mixed race/ethnicity; and having diabetes was associated with higher risk of abnormal urine albumin levels in adjusted analyses. CONCLUSIONS: NKFH-KEDS participants of older age; Asian and Pacific Islander race/ethnicity; and with obesity, hypertension, and diabetes had higher risk of kidney damage defined by elevated ACR and urine albumin levels. Further studies are needed to determine whether targeted screening programs can result in timely identification of CKD and implementation of interventions that reduce cardiovascular disease, death, and progression to end-stage renal disease.
BACKGROUND: The value of chronic kidney disease (CKD) screening in the general population remains unclear but may be beneficial in populations with high disease prevalence. We examined risk factors for albuminuria among participants in a state-wide CKD screening program in Hawaii. METHODS: The National Kidney Foundation of Hawaii Kidney Early Detection Screening (NKFH-KEDS) program held 19 CKD screening events from 2006 to 2012. Participants rotated through 5 stations during which sociodemographic, blood glucose, urine albumin-to-creatinine ratio (ACR), and spot urine albumin data were collected. Multivariate logistic regression analyses (adjusted for age, sex, race/ethnicity, body mass index [BMI]) were used to identify clinical predictors of abnormal ACR (≥30 μg/mg) and abnormal spot urine albumin (>20 mg/L) levels. RESULTS: Among 1,190 NKFH-KEDS participants who met eligibility criteria, 13 and 49% had abnormal ACR and urine albumin levels, respectively. In multivariate logistic regression analyses, participants of older age (>65 years), Asian and Pacific Islander race/ethnicity, BMI ≥30 kg/m2, and with hypertension had higher risk of abnormal ACR. Being of older age; Asian, Pacific Islander, and Mixed race/ethnicity; and having diabetes was associated with higher risk of abnormal urine albumin levels in adjusted analyses. CONCLUSIONS: NKFH-KEDS participants of older age; Asian and Pacific Islander race/ethnicity; and with obesity, hypertension, and diabetes had higher risk of kidney damage defined by elevated ACR and urine albumin levels. Further studies are needed to determine whether targeted screening programs can result in timely identification of CKD and implementation of interventions that reduce cardiovascular disease, death, and progression to end-stage renal disease.
Authors: Merle R Kataoka-Yahiro; Kamomilani Anduha Wong; Jill Tamashiro; Victoria Page; Julaine Ching; Dongmei Li Journal: Hawaii J Med Public Health Date: 2012-07
Authors: Marije van der Velde; Kunihiro Matsushita; Josef Coresh; Brad C Astor; Mark Woodward; Andrew Levey; Paul de Jong; Ron T Gansevoort; Marije van der Velde; Kunihiro Matsushita; Josef Coresh; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Ron T Gansevoort; Andrew Levey; Meguid El-Nahas; Kai-Uwe Eckardt; Bertram L Kasiske; Toshiharu Ninomiya; John Chalmers; Stephen Macmahon; Marcello Tonelli; Brenda Hemmelgarn; Frank Sacks; Gary Curhan; Allan J Collins; Suying Li; Shu-Cheng Chen; K P Hawaii Cohort; Brian J Lee; Areef Ishani; James Neaton; Ken Svendsen; Johannes F E Mann; Salim Yusuf; Koon K Teo; Peggy Gao; Robert G Nelson; William C Knowler; Henk J Bilo; Hanneke Joosten; Nanno Kleefstra; K H Groenier; Priscilla Auguste; Kasper Veldhuis; Yaping Wang; Laura Camarata; Beverly Thomas; Tom Manley Journal: Kidney Int Date: 2011-02-09 Impact factor: 10.612
Authors: Yoshio N Hall; Chi-yuan Hsu; Carlos Iribarren; Jeanne Darbinian; Charles E McCulloch; Alan S Go Journal: Kidney Int Date: 2005-11 Impact factor: 10.612
Authors: Marjorie K Mau; Margaret West; Jared Sugihara; Martina Kamaka; Judy Mikami; Shiuh-Feng Cheng Journal: J Natl Med Assoc Date: 2003-10 Impact factor: 1.798
Authors: Alka M Kanaya; Ann W Hsing; Sela V Panapasa; Namratha R Kandula; Maria Rosario G Araneta; Daichi Shimbo; Paul Wang; Scarlett L Gomez; Jinkook Lee; K M Venkat Narayan; Marjorie K L Mala Mau; Sonali Bose; Martha L Daviglus; Frank B Hu; Nadia Islam; Chandra L Jackson; Merle Kataoka-Yahiro; John S K Kauwe; Simin Liu; Grace X Ma; Tung Nguyen; Latha Palaniappan; V Wendy Setiawan; Chau Trinh-Shevrin; Janice Y Tsoh; Dhananjay Vaidya; Barbara Vickrey; Thomas J Wang; Nathan D Wong; Sean Coady; Yuling Hong Journal: Ann Intern Med Date: 2022-01-04 Impact factor: 51.598
Authors: Ikechi G Okpechi; Fergus J Caskey; Abduzhappar Gaipov; Elliot K Tannor; Jean Jacques Noubiap; Emmanuel Effa; Udeme E Ekrikpo; Laura N Hamonic; Gloria Ashuntantang; Aminu K Bello; Jo-Ann Donner; Ana E Figueiredo; Reiko Inagi; Magdalena Madero; Charu Malik; Monica Moorthy; Roberto Pecoits-Filho; Vladimir Tesar; Adeera Levin; Vivekanand Jha Journal: Kidney Int Rep Date: 2022-04-06
Authors: Alvaro Sobrinho; Leandro Dias da Silva; Angelo Perkusich; Maria Eliete Pinheiro; Paulo Cunha Journal: BMC Med Inform Decis Mak Date: 2018-01-12 Impact factor: 2.796